Journal Article

A Comparison of the Validity of Gas Chromatography-Mass Spectrometry and Liquid Chromatography-Tandem Mass Spectrometry Analysis of Urine Samples II: Amphetamine, Methamphetamine, (±)-3,4-Methylenedioxyamphetamine, (±)-3,4-Methylenedioxymethamphetamine, (±)-3,4-Methylenedioxyethylamphetamine, Phencyclidine, and (±)-11-nor-9-Carboxy-Δ<sup>9</sup>-tetrahydrocannabinol*

Peter R. Stout, Nichole D. Bynum, Cynthia M. Lewallen, John M. Mitchell, Michael R. Baylor and Jeri D. Ropero-Miller

in Journal of Analytical Toxicology

Volume 34, issue 8, pages 430-443
Published in print October 2010 | ISSN: 0146-4760
Published online October 2010 | e-ISSN: 1945-2403 | DOI: http://dx.doi.org/10.1093/jat/34.8.430
A Comparison of the Validity of Gas Chromatography-Mass Spectrometry and Liquid Chromatography-Tandem Mass Spectrometry Analysis of Urine Samples II: Amphetamine, Methamphetamine, (±)-3,4-Methylenedioxyamphetamine, (±)-3,4-Methylenedioxymethamphetamine, (±)-3,4-Methylenedioxyethylamphetamine, Phencyclidine, and (±)-11-nor-9-Carboxy-Δ9-tetrahydrocannabinol*

More Like This

Show all results sharing these subjects:

  • Medical Toxicology
  • Toxicology (Non-medical)

GO

Show Summary Details

Preview

On November 25, 2008, the U.S. Department of Health and Human Services posted a final notice in the Federal Register authorizing the use of liquid chromatography-tandem mass spectrometry (LC-MS-MS) and other technologies in federally regulated workplace drug testing (WPDT) programs. To support this change, it is essential to explicitly demonstrate that LC-MS-MS, as a technology, can produce results at least as valid as gas chromatography (GC)-MS, the long-accepted standard in confirmatory analytical technologies for drugs of abuse. A series of manufactured control urine samples (n = 10 for each analyte) containing amphetamine, methamphetamine, (±)-3,4-methylenedioxyamphetamine, (±)-3,4-methylenedioxymethamphetamine, (±)-3,4-methylenedioxyethylamphetamine, phencyclidine, and (±)-11-nor-9-carboxy-Δ9-tetrahydrocannabinol at concentrations ranging from 10% to 2000% of federal cutoffs were analyzed with replication by five federally regulated laboratories using GC-MS and at RTI International using LC-MS-MS. Interference samples as described in the National Laboratory Certification Program 2009 Manual were analyzed by GC-MS and LC-MS-MS as well as previously confirmed urine specimens of WPDT origin. Matrix effects were assessed for LC-MS-MS. Results indicated that LC-MS-MS analysis produced results at least as precise, accurate, and specific as GC-MS for the analytes investigated in this study. Matrix effects, while evident, could be controlled by the use of matrix-matched controls and calibrators with deuterated internal standards.

Journal Article.  0 words. 

Subjects: Medical Toxicology ; Toxicology (Non-medical)

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.